Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Supports Cialis Spontaneity With Internet Trial, Direct Patient Data

Executive Summary

Lilly's program to create a "spontaneity" advantage for its erectile dysfunction drug Cialis includes a Phase IIIb trial with direct patient observation reports from an electronic reporting system developed by the California clinical trials firm, 1747, Inc

You may also be interested in...



Pfizer Near Resolution Of GMP Warning Letter; Lilly, Merck Provide Updates

Pfizer expects a re-inspection of its Terre Haute, Ind. injectable manufacturing facility before the end of the month, the company told investors during an April 17 conference call

Pfizer Near Resolution Of GMP Warning Letter; Lilly, Merck Provide Updates

Pfizer expects a re-inspection of its Terre Haute, Ind. injectable manufacturing facility before the end of the month, the company told investors during an April 17 conference call

Lilly/Icos Cialis Marketing Plan Will Target Four Million Former Viagra Users

Marketing efforts for Lilly/Icos' pending erectile dysfunction treatment Cialis will target the approximately four million patients who have discontinued Pfizer's Viagra (sildenafil).

Related Content

UsernamePublicRestriction

Register

PS039713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel